Startups Meet Pharma brings together in one frame (i) big pharma companies posing specific problems in their area of interest and (ii) start-ups developing innovative technologies and services representing potential solutions for the selected challenges.
In 2021 we have partnered with five pharma companies, Takeda, Merck, Amgen, AstraZeneca, and Abbott, and we now invite start-ups to jointly address the challenges they face with operational products and services.
If you are developing innovative technologies and services representing potential solutions for the selected challenges for 2021, submit your application now!
Healthcare personnel perceive diagnosing adult ADHD as a complex and time-consuming task. Digital solutions can offer help for clinical decision making, support for diagnosis, personalised treatment, and treatment response monitoring. Solutions for this challenge may include but are not limited to: gamification, AR/VR, ML/AI, wearables, sensors, IoT, etc.
Chronic Kidney Disease (CKD) is under-diagnosed and under-recognised by healthcare providers. There is a need for a holistic approach, starting with an understanding of risk factors and adequate treatment and disease monitoring. The ideal solution for this challenge should be: (a) a digital solution for patients and healthcare personnel to improve early-stage CKD diagnosis and monitoring; or (b) solution/technology to inter-connect all specialities involved in CKD Diagnosis, treatment management and monitoring.
The key focus of the challenge is about digital remote monitoring and support solutions for patients with MS. The solutions would be used for monitoring disease evolution and/or monitoring of the patient’s quality of life and/or support patients to manage symptoms and maintain high adherence to therapies based on orals medication. These solutions would be used for marketed drugs in real-world environment & during clinical trials.
Clinical trials are becoming more and more complex. Patient identification based on specific criteria and profile is a key element of site feasibility. Current solutions do not allow to estimate recruitment potential in a timely manner and there is a need of innovative solutions to manage the identification and triaging of patients in clinical trials. The ideal solution should allow better patient identification, higher recruitment and support for data management.
Age-related loss of muscle mass and strength leads to loss of physical function and consequently, it presents major health and economic burden to society. Currently, there is low awareness of age-related muscle and strength loss due to a lack of easy screening/ diagnostic tools. The key focus of the challenge is easy screening/ diagnostic tools that identify people at risk of muscle mass/ strength/ physical function loss that can be easily integrated into a digital system tied to recommendations for treatment/ management to prevent progression to mobility-disability.